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ABSTRACT
Background and the purpose of the study: A quantitative structure activity relationship (QSAR) 
model based on artificial neural networks (ANN) was developed to study the activities of 
29 derivatives of 3-amino-4-(2-(2-(4-benzylpiperazin-1-yl)-2-oxoethoxy) phenylamino) 
cyclobutenedione as C-C chemokine receptor type 1(CCR1) inhibitors.
Methods: A feed-forward ANN with error back-propagation learning algorithm was used for 
model building which was achieved by optimizing initial learning rate, learning momentum, 
epoch and the number of hidden neurons. 
Results: Good results  were obtained with a Root Mean Square Error (RMSE) and correlation 
coefficients  (R2) of 0.189 and 0.906 for the training and 0.103 and 0.932 prediction sets, 
respectively.
Conclusion: The  results  reflect  a  nonlinear  relationship  between  the  Principal  components 
obtained from calculated molecular descriptors and the inhibitory activities of the investigated 
molecules. 
Keywords:  Quantitative Structure Activity Relationship, inhibitory activity, feed-forward 
ANN, PCA.
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INTRODUCTION
The chemokine proteins are a class of small 
molecules that play a significant role in leukocyte-
trafficking  during  immune  response  (1).  CCR1, 
as one of the chemokine receptors, is expressed 
on a number of human cells such as monocytes, 
macrophages, dendritic cells, and T cells (2) .A large 
number of studies have provided strong evidences 
for a significant role of the chemokines, RANTES 
(Regulated upon Activation, Normal T cell Expressed 
and presumably Secreted), and MIP-1a (Macrophage 
inflammatory  protein-1)  in  chronic  inflammatory 
diseases. Because MIP-1a and RANTES are agonists 
for CCR1, antagonists for this protein may be helpful 
in treatment of these diseases (3). 
QSAR has become a very well known discipline in 
the drug discovery researches (4-6). The basis of such 
relationships is the assumption that the variation of 
bioactivity of molecules, as expressed by pIC50, can 
be regressed with changes in molecular descriptors. 
Development of QSAR involves selection of most 
informative independent variables to describe 
different sets of molecules and the application 
of various algorithms, such as multiple linear 
regression or ANN to construct the QSAR model. 
The advantage of ANN is it inherent power to reveal 
non-linear relationships between idependent and 
dependent variables in the derivation of the QSAR 
models.
A quantitative structure activity relationship 
(QSAR) model based on artificial neural networks 
(ANN) was developed to study the activities of 29 
derivatives of 3-amino-4-(2-(2-(4-benzylpiperazin-
1-yl)-2-oxoethoxy) phenylamino) cyclobutenedione 
as C-C chemokine receptor type 1(CCR1) inhibitors 
(7). 
 METHODS
Biological and chemical data from 29 derivatives 
of 4-3-amino-4-(2-(2-(4-benzylpiperazin-1-yl)-2-
oxoethoxy)phenylamino)cyclobutenedione were 
used in this study (Table 1) (7). All the structures 
were drawn and optimized using the semiempirical 
quantum-chemical routine of AM1 implemented in 
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Table 1. (Cont.) The structures and biological activities of compounds 9-13
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Table 1. (Cont.) The structures and biological activities of compounds 14-27  
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Hyperchem (8).
In order to model the biological activities of the   
studied compounds, four classes of descriptors were 
calculated: constitutional, geometrical, topological, 
and functional group using Dragon (9) on the 
minimal energy conformations.  The data set  was 
devided into the training and the testing sets based 
on Kennard and Stone algorithm (10). 
Principal component analysis was used to compress 
a pool of descriptors into principal components 
(PCs) as new variables. After that, a model using 
a  nonlinear  regression  model,  artificial  neural 
network, was constructed to make a relationship 
between PCs and the pIC50. A feed-forward ANN 
with error back-propagation learning algorithm was 
applied for model building.
RESULT AND DISCUSSION
Results
PCA was performed on the data set that gives 14 
significant PCs (% variance explaind > 1). Fourteen 
Table 1. (Cont.) The structures and biological activities of compounds 28-29  
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Component Eigenvalues % of Variance Explained Cumulative %
1 470.394 39.495 39.495
2 138.563 11.634 51.130
3 127.783 10.729 61.859
4 79.828 6.702 68.561
5 61.826 5.191 73.752
6 42.604 3.577 77.330
7 36.975 3.104 80.434
8 34.61 2.906 83.340
9 30.600 2.569 85.910
10 23.659 1.986 87.896
11 18.673 1.567 89.464
12 17.002 1.427 90.892
13 14.264 1.197 92.089
14 13.344 1.120 93.210
Table 2 The result of of principal component analysis on the total descriptors.
 
 
Figure 1. The first two components (PC1, and PC2) from the principal component analysis of the 29 studied molecules.
PCs with their eigenvalues are shown in the table 
2.  Therefore, the next steps of study were restricted 
to these 14 PCs. Plotting of first PC vs. second PC 
showed none of the compounds is outlier (Fig. 1).  
Clarification  of  the  theory  of  the  artificial  neural 
networks in details has been adequately described 
elsewhere (11) and some relevant remarks is 
presented. 
Back propagation artificial neural network includes 
three layers. The first layer namely input layer has 
NI neurons, and function of this layer is reception 
of information (i.e. inputs) which transfers them to 
all neurons in the next layer called the hidden layer 
that their number are indicated by NH. The neurons 
in the hidden layer calculate a weighted sum of the 
inputs that is subsequently transformed by a linear or 
non-linear function. The last layer is the output layer 
and its neurons handle the output from the network 
and it calculate response vector. The function of 
synapses is connection of input layer to hidden 
layer and hidden layer to output layer. The manner 
in which each node transforms its input depends 
on the “weights” and bias of the node, which are 
modifiable.  
BA-ANN network was trained with the training set 
of molecules using a back propagation algorithm 
followed by conjugate gradient descent in the 
second stage (4-7). RMSECV was then employed as 
tool to select optimum value of various parameters 
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Figure 3. Optimization of number of neurons in hidden layer (A), momentum (B), and, Learning rate (C).
Figure 2. Optimization of the number of principal components (PCs) to enter the ANN.A QSAR study of some cyclobutenediones as CCR1  382
Table 3 Various statistical parameter for developed PC- ANN model
R2a RMSEb PRESSc R2-R0
2/R2 R2-R'0
2/R2 Kd k'f Rm
2
Training set 0.906 0.189 0.752 -0.102 -0.102 1.001 0.997 0.630
Test Set 0.932 0.103 0.388 -0.072 -0.070 1.003 0.994 0.690
aR2 = Square Regression coefficient
 bRMSE = Root mean square error
cPRESS = predicted error sum of square for training set
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Table 4 Structures and details of the proposed molecules as novel CCR15 inhibitors.
Figure 2 shows the effect of the different number of 
PCs on predictability of developed model. On the 
based of this figure, the ANN has the highest degree 
of predictability when the number of PCs is 4.
The parameters of network which should be 
optimized are learning rate, number of neuron in 
hidden layer, momentum .The optimal values for 
these parameters as it is shown in figures 3A-C are 
1.2, 9, and 0.9, respectively. 
The predicted activity of the ANN calculated 
values of pIC50 versus the experimental values 
are shown in figure 4 and reported in table 1. As 
it was expected, the calculated values are in good 
agreement with the experimental values. 
Various statistical criteria for ANN model were 
calculated and reported in table 3 (5-8). The external 
predictability of a proposed model was generally 
tested using test sets and R2
CV. The satisfactory 
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Figure 4. Calculated vs. experimental activity of the investigated compounds in training and test sets...
prediction of the values of the inhibitory activity 
of the test set compounds demonstrates the efficacy 
of the QSAR in predicting the activities of external 
molecules.
Discussion
In the developed model, a network including a fully 
connected three layer, feed-forward ANN model 
trained with a back-propagation learning algorithm 
was used. The input of the network was the 
eigenvalue ranked PCs, the number of them which 
entered neural network varied from 1 to 14, of which 
4 PCs of them were selected as input of networks. 
By using this number of PCs the best results on the 
basis of lowest RMSECV in the output of network 
were obtained. Since there are no exact theoretical 
principles for choosing the appropriate network 
topology,  before  the training of the network, the 
adjustable parameters as number of nodes in the 
hidden layer, transfer function, learning rate and 
etc. were optimized. The values resulting from 
hidden layer are transferred to the last layer, which 
contains a single neuron representing the predicted 
activity. For output layer a linear transfer function 
was chosen. Various ANN architectures were run 
with the four selected PCs as input. In each run, the 
neuron architecture and parameters were optimized 
to reach the lowest RMSECV as the performances of 
the resulted models. 
According to the criteria proposed by Tropsha 
and Roy (4-6), for testing the reliability and the 
robustness of QSAR models, the obtained model is 
very predictive (Table 3).
As a final point, one could dispute that what does the 
developed model mean to medicinal chemists? As 
discussed above, the calculated PCs have meaning 
physicochemically, but they may be employed 
for building statistical models which help the 
medicinal chemist limit the number of compounds 
to be synthesized. For instance, medicinal chemist 
can propose a training set comprised of molecules 
which have the characters of two or more chemical 
classes with the smallest amount of similarity. Then 
the model can be used to predict the activity of his 
proposed molecules. Therefore, the QSAR model 
was used to estimate inhibitory activities of a few 
suggested compounds. 
The general structures of four suggested compounds 
and also their calculated activities are reported in 
table 4. The suggested compounds are combination 
of the most potent compounds of table 1.  The relative 
high predicted activity of the tested compounds 
suggest further study such as synthesis of other 
compounds with such chemical structures.
CONCLUSION
The main objective of this study was to define and 
establish a QSAR model to predict bioactivity of 
a series of 3-amino-4-(2-(2-(4-benzylpiperazin-1-
yl)-2-oxoethoxy) phenylamino) cyclobutenedione 
derivatives as novel CCR1 antagonists without any 
knowledge of the under study system.
Various theoretical calculated molecular descriptors 
were applied to calculate PCs. Calculated PCs were 
used to make model of the relationship between the 
molecule structures of the studied compounds and 
the corresponding bioactivities. The study showed 
that the calculated PCs as input variable to network 
can improve the predictive ability of the neural 
networks.  Moreover, the suggested QSAR model 
was based on nonlinear ANN approach, which can 
be employed to simulate any kinds of complex 
correlation or function relationship in a given 
multivariable system. i.e., ANN approach is more 
appropriate for modeling where no clearly defined 
mathematical model for a system is available. 
Bioactivity is one of the most important properties 
for a given compound. Therefore, accurate, well-
organized and intelligent QSAR model for the 
bioactivity will be   influential  for drug design and 
development.A QSAR study of some cyclobutenediones as CCR1  384
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